Arcadian Capital
Arcadian Capital Management LLC is a venture capital firm founded in 2017 and based in Los Angeles, California. The firm specializes in thematic investments in early-to-mid-stage growth markets, particularly in sectors influenced by supply chain disruptions. Its primary focus lies within the consumer segments of the health and wellness industry, but it also explores opportunities in non-plant-touching healthcare, life sciences, ag-tech, supply chain infrastructure, technology services, and various consumer product platforms. Through its strategic investments, Arcadian aims to support the emergence and growth of innovative business categories.
Kadenwood
Series B in 2021
Kadenwood is a privately-held consumer products lifestyle company that specializes in cannabidiol (CBD) products aimed at establishing CBD as a trusted and safe option within the mainstream wellness market. The company is committed to quality by utilizing vertically-integrated CBD farming practices, allowing for the production of THC-free CBD oil from seed to shelf. Kadenwood's product offerings include sports creams, roll-ons, oil drops, pet health products, and organic hot teas, all of which comply with farm-bill regulations. Through its focus on quality and innovation, Kadenwood seeks to redefine the CBD industry and promote wellness among its consumers.
Petalfast
Series A in 2021
Petalfast Inc. is a sales and marketing company focused on the cannabis industry, providing a comprehensive suite of services designed to enhance brand visibility and drive growth. Founded in 2020 and based in Middletown, Delaware, Petalfast offers a range of marketing solutions, including brand strategy, graphic identity, packaging design, audience segmentation, retail strategy, and digital content creation. Their sales accelerator comprises six components that can be utilized independently or collectively to maximize impact. By leveraging its marketing expertise, Petalfast assists cannabis brands in developing effective sales strategies, optimizing their market reach, and implementing targeted advertising campaigns. The company's approach is tailored to meet the specific needs of clients in the cannabis sector, enabling them to navigate a competitive landscape and achieve sustainable growth.
Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.
Front Range Biosciences
Series B in 2019
Front Range Biosciences, Inc. is an agricultural biotech company specializing in the breeding and production of new plant varieties and seeds within the hemp, coffee, and cannabis sectors. Founded in 2015 and based in Lafayette, Colorado, with additional offices in Wisconsin, California, and Spain, the company employs tissue culture propagation techniques to enhance the efficiency and consistency of clone and seed production. Their Clean Stock program ensures a supply of disease- and pest-free plants, providing farmers with data-driven solutions to develop new cultivars with commercially relevant traits. Front Range Biosciences aims to modernize agriculture for cannabis and hemp, offering services that support cultivators in improving yields, minimizing disease risks, and creating innovative plant strains.
KelSie Biotech
Series A in 2019
KelSie Biotech, LLC is a biotechnology company based in Boulder, Colorado, focused on the research and development of innovative delivery methods for sensitive active pharmaceutical ingredients (APIs). Established in 2017, the company specializes in creating dry powder formulations, including inhalable products and sublingual wafers, utilizing its patented bubble drying technology. KelSie Biotech offers a comprehensive range of services, including formulation, testing, licensing, trial design, manufacturing, and consulting, aimed at enhancing bioavailability and facilitating easier administration of medications for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.